|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
08-27-2010, 04:13 AM
|
|||
|
|||
Celsion gets US FDA fast track status for ThermoDox development programme to treat pr
Celsion Corporation, a leading oncology drug development company, announced that the US Food and Drug Administration (FDA) has designated the HEAT Study of its investigational drug, ThermoDox, in combination with radiofrequency ablation (RFA), as a Fast Track Development Programme.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Celsion Receives Fast Track Designation For ThermoDox Development Program To Treat Pr | cancerfr | Liver Cancer | 0 | 08-25-2010 08:17 PM |
| FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment | cancerfr | Adrenocortical Carcinoma | 0 | 08-25-2010 08:17 PM |
| Celsion Receives Fast Track Designation for ThermoDox Development Program to Treat Pr | cancerfr | Liver Cancer | 0 | 08-25-2010 02:27 AM |
| Gamida Cell-Teva JV receives US FDA fast track status for StemEx for leukaemia & lymp | cancerfr | Non-Hodgkin Lymphoma | 0 | 06-24-2010 12:35 AM |
| DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary | cancerfr | Neuroblastoma | 0 | 05-14-2010 01:57 PM |
Linear Mode
